Page 4 of Novartis News: Novartis Latest News, Novartis Today news, Novartis Breaking News

Torrent Pharmaceuticals, Torrent Pharma, Curatio healthcare, health news, pharma news,

USFDA accepts Sandoz Supplemental Biologics License Application for biosimilar Hyrimoz

The company claims that Sandoz has more than 65 million days of patient experience with Hyrimoz 50 mg/mL worldwide and…

July 21, 2022 12:22 IST

Spectrum Pharmaceuticals, USFDA, lung cancer drug, poziotinib, Luye Pharma, health news, pharma news,

Novartis’ tislelizumab shows promising survival results in advanced esophageal cancer, Phase 3 data reveals

ESCC is the most common type of esophageal cancer globally, with an estimated 604,000 new cases and 544,000 deaths from…

June 30, 2022 18:00 IST

Novartis shares slide 13 per cent after Q4 results

Shares of drug firm Novartis India slumped 13 per cent intraday on Friday on disappointment over the company’s earnings for…

May 27, 2016 17:13 IST

Novartis splits drugs business into two

David Epstein, Division Head and Chief Executive, Novartis Pharmaceuticals to leave the company Novartis is splitting its pharmaceuticals division into…

May 18, 2016 11:01 IST

Novartis’ Afinitor reduces seizures in patients with tuberous sclerosis complex

Results presented at American Academy of Neurology will be discussed with health authorities for potential worldwide regulatory filings

Updated: April 22, 2016 16:13 IST

Sun Pharmaceutical shares gain on entering Japanese prescription market

According to the agreements entered into between the parties, a wholly-owned subsidiary of Sun Pharma will acquire the portfolio consisting…

March 30, 2016 11:05 IST

Sun Pharma enters Japanese prescription market

Acquires 14 prescription brands Sun Pharma has acquired 14 established prescription brands from Novartis in Japan. According to the agreements…

March 30, 2016 09:11 IST

Aurobindo Pharma receives US FDA approval for rivastigmine tartrate capsules

The product is expected to be launched in Q1 FY16-17

Updated: March 29, 2016 16:06 IST

GlaxoSmithKline posts loss as it integrates new businesses

Drug makers like GSK have been trying to focus on strengths amid competition from generic drug makers British-based drug maker…

February 4, 2016 17:30 IST

Novartis completes animal health business sale transaction

Drug firm Novartis India has completed the transaction to sell its animal health business to Elanco India, an affiliate of…

January 1, 2016 17:04 IST

Novartis’ two major trials shows significant efficacy of Cosentyx in ankylosing spondylitis patients

The study enrolled anti-TNF naïve patients and patients who had previously failed anti-TNF therapy, with clinical benefits demonstrated across the…

December 24, 2015 14:33 IST

Regulatory submission for Sandoz’ proposed biosimilar pegfilgrastim accepted by FDA

Proposed biosimilar pegfilgrastim filing is the second of ten regulatory filings planned over the next three years Sandoz, a Novartis…

November 18, 2015 14:53 IST

India needs predictable IPR regime: Novartis

A “highly predictable” IPR regime is needed for the pharma industry in India to develop to the level of the…

November 17, 2015 17:29 IST

Novartis India Q2 net rises multi-fold to Rs 104 crore

Pharma company Novartis India today reported a multi-fold jump in its stand-alone net profit at Rs 103.82 crore for the…

November 5, 2015 12:48 IST

Novartis gets USFDA warning letter for two plants in India

Sandoz, the generic drug arm of Swiss drug major Novartis, has received a warning letter from the US health regulator…

October 29, 2015 09:56 IST

Kenya launches ‘Novartis Access’

Agreements signed with Kenyan government and NGOs include programmes to distribute medicines, raise disease awareness and strengthen healthcare system capabilities…

October 15, 2015 12:20 IST

Novartis launches access programme for 15 medicines

Novartis Access to be launched first in Kenya, Ethiopia and Vietnam Novartis has launched Novartis Access, a portfolio of 15…

September 24, 2015 13:41 IST

Sandoz launches Zarxio, the first biosimilar in US

Sandoz One Source, a patient services centre, was also launched Zarxio by Sandoz, a Novartis company, is now available in…

September 3, 2015 14:31 IST